DaVita Inc (DVA)
163.08
+0.82
(+0.51%)
USD |
NYSE |
Sep 27, 16:00
163.03
-0.05
(-0.03%)
Pre-Market: 20:00
DaVita SG&A Expense (Annual): 1.474B for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.474B |
| December 31, 2022 | 1.355B |
| December 31, 2021 | 1.195B |
| December 31, 2020 | 1.248B |
| December 31, 2019 | 1.103B |
| December 31, 2018 | 1.135B |
| December 31, 2017 | 1.064B |
| December 31, 2016 | 1.073B |
| December 31, 2015 | 1.031B |
| December 31, 2014 | 1.262B |
| December 31, 2013 | 1.176B |
| December 31, 2012 | 889.88M |
| December 31, 2011 | 684.72M |
| December 31, 2010 | 571.82M |
| December 31, 2009 | 531.53M |
| Date | Value |
|---|---|
| December 31, 2008 | 508.24M |
| December 31, 2007 | 627.92M |
| December 31, 2006 | 579.72M |
| December 31, 2005 | 334.38M |
| December 31, 2004 | 230.87M |
| December 31, 2003 | 193.59M |
| December 31, 2002 | 180.95M |
| December 31, 2001 | 126.90M |
| December 31, 2000 | 163.27M |
| December 31, 1999 | 263.81M |
| December 31, 1998 | 120.60M |
| December 31, 1997 | 78.80M |
| December 31, 1996 | 48.10M |
| December 31, 1995 | 14.60M |
| May 31, 1995 | 11.50M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
1.103B
Minimum
2019
1.474B
Maximum
2023
1.275B
Average
1.248B
Median
2020
SG&A Expense (Annual) Benchmarks
| Quest Diagnostics Inc | 1.642B |
| Universal Health Services Inc | 7.249B |
| Encompass Health Corp | 2.858B |
| Boston Scientific Corp | 5.19B |
| Stryker Corp | 7.129B |